Fonte: Journal of pediatric endocrinology and metabolism. Nome do evento: Annual Meeting of the Sociedad Latinoamericana de Endocrinologia Pediátrica (SLEP). Unidade: FM
Assuntos: PUBERDADE PRECOCE (GENÉTICA), MUTAÇÃO GENÉTICA, BIOMARCADORES, GONADOTROFINAS, DOR (TERAPIA), ANALGÉSICOS (USO TERAPÊUTICO), RESUMOS (CONGRESSOS)
ABNT
TELES, M. G. et al. The effects of pamidronate treatment in girls with polyostotic fibrous dysplasia in McCune Albright syndrome. Journal of pediatric endocrinology and metabolism. London: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 30 set. 2024. , 2004APA
Teles, M. G., Brito, V. N., d´Alva, C., Arnhold, I. J. P., Mendonça, B. B., & Latronico, A. C. (2004). The effects of pamidronate treatment in girls with polyostotic fibrous dysplasia in McCune Albright syndrome. Journal of pediatric endocrinology and metabolism. London: Faculdade de Medicina, Universidade de São Paulo.NLM
Teles MG, Brito VN, d´Alva C, Arnhold IJP, Mendonça BB, Latronico AC. The effects of pamidronate treatment in girls with polyostotic fibrous dysplasia in McCune Albright syndrome. Journal of pediatric endocrinology and metabolism. 2004 ; 17( suppl.5): 1354.[citado 2024 set. 30 ]Vancouver
Teles MG, Brito VN, d´Alva C, Arnhold IJP, Mendonça BB, Latronico AC. The effects of pamidronate treatment in girls with polyostotic fibrous dysplasia in McCune Albright syndrome. Journal of pediatric endocrinology and metabolism. 2004 ; 17( suppl.5): 1354.[citado 2024 set. 30 ]